Solvay Pharmaceuticals, Inc. Awards 40 Scholarships to Students with Cystic Fibrosis
Marietta, Ga. — December 12, 2006 — Solvay Pharmaceuticals, Inc. has selected 40 students with cystic fibrosis (CF) to receive a 2006-2007 CREON® Family Scholarship. These winners are being recognized for their academic excellence as well as their courage in battling CF, an incurable genetic disease.
Each student receives $2,000 per year for up to two years of study and a year’s supply of CREON® MINIMICROSPHERES® (pancrelipase delayed-release capsules, USP) and SourceCF® Softgels Multivitamins. At the end of each two-year award period, recipients are eligible to apply for additional scholarship funding.
Now in its 14th year, the CREON® Family Scholarship program is funded by Solvay Pharmaceuticals. Since the program’s inception, the company has awarded more than 300 scholarships totaling nearly $2 million. Scholarships are awarded to students based on academic achievement, financial need, leadership qualities and the ability to serve as a role model to others with CF. All U.S. citizens with CF who are high school seniors, vocational school students or college students are eligible to apply. Applications are available at CF treatment centers nationwide each year from March through June.
The 2006-2007 scholarship award recipients are:
Wendy Abrams - Miami
Michael Alfund - Branchville, N.J.
Kerry Bannon - West Hartford, Conn.
Jessika Biele - Holiday, Fla
Kenneth Boutot - Hillsborough, N.J.
Bailey Broadbent - Canton, Ohio
Tiffany Brock - Chandler, Ariz.
Casandra Caminiti - Lapeer, Mich.
Rebecca Duckworth - Paradise Valley, Ariz.
Brittney Dye - Edmond, Okla.
Jason Fick - Eugene, Ore.
Sarah File - Beckley, W.Va.
Christopher Frazier - Carlsbad, Calif.
Amy Freed - Williamsport, Pa.
Michelle Green - Medina, Ohio
Bess Harris - Nicholson, Ga.
Bethany Hawes - Montfort, Wis.
Janessa Henderson - Henryetta, Okla.
Caroline Henry - Meriden, Conn.
Preston Blair Holland - Henderson, Texas
Jeremiah Hudson - Freeport, Texas
Michael Klenk - Kettering, Ohio
Anya Knecht - Homer, Ill.
Meleah Lambert - Eugene, Ore.
Katie Leighton - Bar Harbor, Maine
Dustin Lussier - Milton, Vt.
Kyleigh McCoy -Edmond, Okla.
John McLennan - Lamar, Mo.
Matthew Lake Morris - Anderson, S.C.
Kellisa Myers - Lakewood, Calif.
Merced Ramey - Orem, Utah
Wade Roberts - Syracuse, Utah
Laura Robertson - Hazel Green, Wis.
Claudia Smith - Roanoke Rapids, N.C.
Kate Sulikowski - Somers, Conn.
Kay Szydlowski - Lakeland, Fla.
Nathan Tallent - Lexington, Ky.
Abigail Turner - Grand Prairie, Texas
Amanda Tutor - Wilmington, Ill.
Scott Wedman - Lawrence, Kan.
"This year’s scholarship winners are true role models,” said Laurence Downey, M.D., president and chief executive officer of Solvay Pharmaceuticals, Inc. "They have overcome tremendous obstacles throughout their lives and have demonstrated courage, resolve and a drive for excellence. We are honored to support their educational goals with these scholarships."
About CREON® MINIMICROSPHERES®
CREON® MINIMICROSPHERES® is indicated for CF patients with pancreatic exocrine insufficiency. The most frequently reported adverse reactions to pancreatic enzyme-containing products are gastrointestinal in nature, which may include nausea, vomiting, bloating, cramping, constipation or diarrhea. Less frequently, allergic-type reactions have also been observed. Very high doses of pancreatin have been associated with hyperuricosuria and hyperuricemia. Full prescribing information is available at www.solvaypharmaceuticals-us.com.
About Solvay Pharmaceuticals, Inc. Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.
Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, specialized markets and men’s and women’s health. Its 2005 sales were EUR 2.3 billion and it employs approximately 10,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com
SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs some 30,000 people in 50 countries. In 2005 its consolidated sales amounted to EUR 8.6 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. SOLVAY (Euronext : SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the Euronext stock exchange in Brussels. Details are available at www.solvay.com.
